TVARDI THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
TVARDI THERAPEUTICS, INC. (TVRD) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $3.43 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2016-03-11
- TVARDI THERAPEUTICS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2013-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2013-09-30 was $949.00K.
- TVARDI THERAPEUTICS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2013-06-30 was $1.46M.
- TVARDI THERAPEUTICS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2013-03-31 was $1.02M.
- TVARDI THERAPEUTICS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2013 was $3.43M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $949.00K derived: sum of 2 quarters · filed 2016-03-11 | $2.41M derived: sum of 3 quarters · filed 2016-03-11 | $3.43M 10-K · filed 2016-03-11 |
| 2013-09-30 | $949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.41M derived: sum of 2 quarters · filed 2014-11-10 | $3.43M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.48M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $1.02M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |